PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy

Gold Nanoparticles for the Improved Anticancer Drug Delivery of the Active Component of Oxaliplatin

Sarah D. Brown, Paola Nativo, J.L. Smith et al. · Journal of the American Chemical Society · 2010 · 855 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Soluble Polymer Carriers for the Treatment of Cancer: The Importance of Molecular Architecture

Megan E. Fox, Francis C. Szoka, Jean M. J. Fréchet · Accounts of Chemical Research · 2009 · 741 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

Dana D. Hu‐Lowe, Helen Y. Zou, Maren L. Grazzini et al. · Clinical Cancer Research · 2008 · 628 citations

Medicine, Oncology, Pharmacology +17

High Expression of Macrophage Colony-Stimulating Factor in Peritumoral Liver Tissue Is Associated With Poor Survival After Curative Resection of Hepatocellular Carcinoma

Xiao‐Dong Zhu, Jubo Zhang, Peng–Yuan Zhuang et al. · Journal of Clinical Oncology · 2008 · 550 citations

Medicine, Oncology, Pathology +17

Clinical pharmacokinetics of oxaliplatin: a critical review.

Martin A. Graham, G. Lockwood, Dennis Greenslade et al. · PubMed · 2000 · 461 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +15